Additionally, TPM4, the suppression of which can inhibit metastasis in in hepatocellular carcinoma (HCC) [76], showed significantly higher levels in glioma than in healthy brain tissue, which correlated with poor prognosis of patients [77]. Here, TPM4 is linked to hepatocellular carcinoma.